Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:5310718.
doi: 10.1155/2016/5310718. Epub 2016 Jun 20.

Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review

Affiliations
Review

Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review

Samuel A Sakyi et al. Can J Infect Dis Med Microbiol. 2016.

Abstract

Background. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbid effects and misuse of drugs. We review developments in laboratory diagnosis of BU, discuss limitations of available diagnostic methods, and give a perspective on the potential of using aptamers as point-of-care. Methods. Information for this review was searched through PubMed, web of knowledge, and identified data up to December 2015. References from relevant articles and reports from WHO Annual Meeting of the Global Buruli Ulcer initiative were also used. Finally, 59 articles were used. Results. The main laboratory methods for BU diagnosis are microscopy, culture, PCR, and histopathology. Microscopy and PCR are used routinely for diagnosis. PCR targeting IS2404 is the gold standard for laboratory confirmation. Culture remains the only method that detects viable bacilli, used for diagnosing relapse and accrued isolates for epidemiological investigation as well as monitoring drug resistance. Laboratory confirmation is done at centers distant from endemic communities reducing confirmation to a quality assurance. Conclusions. Current efforts aimed at developing point-of-care diagnostics are saddled with major drawbacks; we, however, postulate that selection of aptamers against MU target can be used as point of care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic selection of review articles.
Figure 2
Figure 2
Histopathological images of Buruli ulcer disease.

Similar articles

Cited by

References

    1. Amofah G., Bonsu F., Tetteh C., et al. Buruli ulcer in Ghana: results of a national case search. Emerging Infectious Diseases. 2002;8(2):167–170. doi: 10.3201/eid0802.010119. - DOI - PMC - PubMed
    1. Johnson P. D. R., Stinear T., Small P. L. C., et al. Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Medicine. 2005;2(4, article e108) doi: 10.1371/journal.pmed.0020108. - DOI - PMC - PubMed
    1. WHO. Buruli ulcer: progress report, 2004–2008. Weekly Epidemiological Record. 2008;83(17):145–154. - PubMed
    1. van der werf T. S., van der Graaf W. T. A., Tappero J. W., Asiedu K. Mycobacterium ulcerans infection. The Lancet. 1999;354(9183):1013–1018. doi: 10.1016/s0140-6736(99)01156-3. - DOI - PubMed
    1. Ellen D. E., Stienstra Y., Teelken M. A., Dijkstra P. U., Van Der Graaf W. T. A., Van Der Werf T. S. Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Tropical Medicine & International Health. 2003;8(1):90–96. doi: 10.1046/j.1365-3156.2003.00976.x. - DOI - PubMed

LinkOut - more resources